<DOC>
	<DOCNO>NCT00049231</DOCNO>
	<brief_summary>RATIONALE : Knowing level oxygen tumor tissue may help predict effectiveness anticancer therapy . EF5 may effective measure oxygen tumor tissue help predict effectiveness anticancer therapy . PURPOSE : Diagnostic trial study effectiveness EF5 detect tumor hypoxia patient stage IIB , stage IIIB , stage IVA cervical cancer .</brief_summary>
	<brief_title>EF5 Detect Tumor Hypoxia Patients With Stage IIB , Stage IIIB , Stage IVA Cervical Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine relationship level EF5 bind pretreatment hemoglobin level , tumor size , stage disease patient stage IIB , IIIB , IVA cervical cancer . - Determine whether pretreatment tumor hypoxia ( measure EF5 bind ) associate overall survival , progression-free interval , local control patient . - Determine relationship EF5 bind CD-31 labeling ( tumor vasculature ) Ki-67 labeling ( cellular proliferation ) patient . OUTLINE : This multicenter study . Patients receive EF5 IV 1-2.5 hour day 1 . Tumor hypoxia measure use immunohistochemical technique . Biopsies collect 1-2 day later . Blood collect EF5 administer time surgery . Patients follow approximately 1 month surgery . PROJECTED ACCRUAL : A total 150 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm invasive squamous cell carcinoma , adenocarcinoma , adenosquamous carcinoma cervix Stage IIB , IIIB , IVA Primary disease No prior treatment Must enrol GOG0191 protocol PATIENT CHARACTERISTICS : Age 18 Performance status GOG 03 Life expectancy Not specify Hematopoietic See Disease Characteristics Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 1.5 time normal SGOT great 3 time normal Alkaline phosphatase great 3 time normal Hemoglobin le 13 g/dL Renal Creatinine great 2 mg/dL Cardiovascular No cardiac disease would preclude safe administration necessary fluid volume Pulmonary No chronic pulmonary disease would preclude safe administration necessary fluid volume Other No history grade 3 4 peripheral neuropathy Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Must weigh 180 kg PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2005</verification_date>
	<keyword>cervical adenocarcinoma</keyword>
	<keyword>cervical adenosquamous cell carcinoma</keyword>
	<keyword>cervical squamous cell carcinoma</keyword>
	<keyword>stage IIB cervical cancer</keyword>
	<keyword>stage III cervical cancer</keyword>
	<keyword>stage IVA cervical cancer</keyword>
</DOC>